Phenomic AI Companies

Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.

Founded Date: 2017-01-01
Technology: Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Funding Status: Seed
Total Funding: 11391214.0
Employee Number: 5
Headquarters: Toronto, Ontario, Canada
Last Funding Date: 2020-10-07
Investors Number: 13.0
Last Funding Type: Seed
Estimated Revenue: $6 million
Industry: BioTech & Health Care